LUDOVICA MARANDO to Lymphoma, Non-Hodgkin
This is a "connection" page, showing publications LUDOVICA MARANDO has written about Lymphoma, Non-Hodgkin.
Connection Strength
0.210
-
A Phase I/II Open-Label Study of Molibresib for the Treatment of Relapsed/Refractory Hematologic Malignancies. Clin Cancer Res. 2023 02 16; 29(4):711-722.
Score: 0.189
-
Paroxysmal nocturnal hemoglobinuria after autologous stem cell transplantation: extinction of the clone during treatment with eculizumab - pathophysiological implications of a unique clinical case. Acta Haematol. 2011; 126(2):103-9.
Score: 0.021